Clinical Research Network on Antimicrobial Resistance
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for a Clinical Research Network on Antimicrobial Resistance (AMR). AMR is a major health challenge that limits treatment options and allows resistant infections to persist. Individuals with chronic condi
| Agency | National Institutes of Health |
|---|---|
| Status | Forecasted |
| Opportunity number | RFA-AI-27-005 |
| Posted date | 12/29/2025 |
| Estimated total funding | 15,000,000 |
| Expected number of awards | 1 |
| Who can apply | Other Eligible ApplicantsFaith-based or Community-based Organizations;Regional Organizations |
| Assistance Listing (CFDA) | 93.855 |
| Description | The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for a Clinical Research Network on Antimicrobial Resistance (AMR). AMR is a major health challenge that limits treatment options and allows resistant infections to persist. Individuals with chronic conditions like diabetes and cancer are particularly vulnerable, resulting in increased illness and death as well as higher healthcare costs in the United States. The program aims to design, implement, and manage clinical research addressing key clinical questions in AMR. Research will focus on bacterial and fungal infections associated with AMR. Areas of emphasis include clinical testing of new antibiotics and other treatments such as bacteriophage therapy, methods optimizing the |
| Agency contact | AMRClinicalResearchNetworkContact@mail.nih.gov |
| Official listing | https://www.grants.gov/search-results-detail/361065 |